Stay updated on Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.

Latest updates to the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPage footer revision label updated from v3.2.0 to v3.3.2; no study content or functionality appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedNotice about government funding and operating status has been removed. Core study details and participation information are unchanged.SummaryDifference0.4%

- Check47 days agoChange Detected- No significant additions or deletions detected; the page content, including study title, design, eligibility criteria, and outcome measures, remains unchanged.SummaryDifference0.5%

- Check75 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

- Check82 days agoChange DetectedUpdate: version tag upgraded from v3.0.2 to v3.1.0, replacing the old revision with a new one. No other content changes detected.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page revision is updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab vs Methotrexate in Elderly Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Methotrexate in Elderly Clinical Trial page.